News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Melincoff Gwen A
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Melincoff Gwen A (Director) has filed a Form 4 on Protalix BioTherapeutics, Inc.|
Txns:
| Granted 61,676 options to buy
@ $1.66, valued at
$102.4k
|
|
| 05/26/2023 |
4
| Melincoff Gwen A (Director) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Granted 2,666 options to buy
@ $5.03, valued at
$13.4k
Granted 10,000 options to buy
@ $5.25, valued at
$52.5k
|
|
| 05/19/2023 |
4
| Melincoff Gwen A (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Granted 9,792 shares
@ $0 |
|
| 10/14/2022 |
4
| Melincoff Gwen A (Director) has filed a Form 4 on SOLENO THERAPEUTICS INC |
| 10/14/2022 |
4
| Melincoff Gwen A (Director) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Granted 2,666 options to buy
@ $0 |
|
| 09/22/2022 |
4
| Melincoff Gwen A (Director) has filed a Form 4 on Gain Therapeutics, Inc.|
Txns:
| Granted 10,500 options to buy
@ $3.5, valued at
$36.8k
|
|
| 09/09/2022 |
4
| Melincoff Gwen A (Director) has filed a Form 4 on Protalix BioTherapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.03, valued at
$51.5k
|
|
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/22/2020 |
4
| Melincoff Gwen A (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Granted 4,047 shares
@ $0
Granted 8,095 options to buy
@ $22.05, valued at
$178.5k
|
|
| 05/20/2020 |
4
| Melincoff Gwen A (Director) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Granted 9,530 options to buy
@ $3.41, valued at
$32.5k
|
|
| 01/22/2020 |
4
| Melincoff Gwen A (Director) has filed a Form 4 on Protalix BioTherapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $3.55, valued at
$142k
|
|
| 11/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2019 |
4
| Melincoff Gwen A (Director) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Granted 13,000 options to buy
@ $2.5, valued at
$32.5k
|
|
| 04/29/2019 |
4
| Melincoff Gwen A (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Granted 4,707 shares
@ $0
Granted 9,414 options to buy
@ $14.57, valued at
$137.2k
|
|
| 04/29/2019 |
4
| Melincoff Gwen A (Director) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Granted 20,000 options to buy
@ $1.98, valued at
$39.6k
|
|
| 05/29/2018 |
4
| Melincoff Gwen A (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Granted 2,253 shares
@ $0
Granted 4,506 options to buy
@ $24.95, valued at
$112.4k
|
|
| 08/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2016 |
4
| Melincoff Gwen A (Director) has filed a Form 4 on Tobira Therapeutics, Inc.|
Txns:
| Disposed/sold 13,539 options to buy
@ $8.13, valued at
$110.1k
Disposed/sold 15,500 options to buy
@ $16.52, valued at
$256.1k
Disposed/sold 17,778 options to buy
@ $7.91, valued at
$140.6k
|
|
|
|